Back
Recursion Pharmaceuticals Vs. Novo Nordisk AS Industry Stock Comparison
Sell
35
RXRX
Recursion Pharmaceuticals
Last Price:
$4.42
Seasonality Move:
41.02%
Buy
62
NONOF
Novo Nordisk AS
Last Price:
$68.01
Seasonality Move:
3.38%
Sell
35
Recursion Pharmaceuticals (RXRX)
is a Sell
Is Recursion Pharmaceuticals a Buy, Sell or Hold?
-
The current Recursion Pharmaceuticals [RXRX] share price is $4.51. The Score for RXRX is 35, which is 30% below its historic median score of 50, and infers higher risk than normal.
-
RXRX is currently trading in the 30-40% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
62
Novo Nordisk AS (NONOF)
is a Buy
Is Novo Nordisk AS a Buy, Sell or Hold?
-
The current Novo Nordisk AS [NONOF] share price is $66.00. The Score for NONOF is 62, which is 24% above its historic median score of 50, and infers lower risk than normal.
-
NONOF is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
-
This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.
RXRX Stock Price Chart
What is Recursion Pharmaceuticals's stock price today?
-
The Recursion Pharmaceuticals share price today is $4.51Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and RXRX is experiencing buying pressure, which is a positive indicator for future bullish movement.
NONOF Stock Price Chart
What is Novo Nordisk AS's stock price today?
-
The Novo Nordisk AS share price today is $66.00The current trend is relatively stagnant and NONOF is experiencing slight buying pressure.
RXRX Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.33 | Sell |
Relative Strength Index (14 RSI): | 42.28 | Sell |
Chaikin Money Flow: | 13569185 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (4.47 - 5.69) | Sell |
Bollinger Bands (100): | (5.03 - 7.91) | Sell |
NONOF Technical Analysis
Chart Indicators | Level | Buy or Sell |
---|---|---|
MACD (12, 26): | -0.66 | Sell |
Relative Strength Index (14 RSI): | 50.36 | Buy |
Chaikin Money Flow: | 28868 | - |
Bollinger Bands | Level | Buy or Sell |
---|---|---|
Bollinger Bands (25): | (61.56 - 66.88) | Buy |
Bollinger Bands (100): | (66.64 - 86.52) | Sell |
RXRX Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 4.44 | Buy |
20-day SMA: | 4.98 | Sell |
50-day SMA: | 5.4 | Sell |
200-day SMA: | 6.63 | Sell |
8-day EMA: | 4.51 | Sell |
20-day EMA: | 4.81 | Sell |
50-day EMA: | 5.44 | Sell |
200-day EMA: | 6.69 | Sell |
NONOF Moving Averages
Moving Averages | Level | Buy or Sell |
---|---|---|
8-day SMA: | 64.93 | Buy |
20-day SMA: | 64.78 | Buy |
50-day SMA: | 67.91 | Sell |
200-day SMA: | 97.87 | Sell |
8-day EMA: | 65.07 | Buy |
20-day EMA: | 65.26 | Buy |
50-day EMA: | 69.14 | Sell |
200-day EMA: | 90.28 | Sell |
Recursion Pharmaceuticals Earnings Growth & RXRX Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.01 per share, an increase next quarter of $0.00 per share, an increase this year of $0.08 per share, and an increase next year of $0.25 per share.
Novo Nordisk AS Earnings Growth & NONOF Earnings Dates
-
Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $0.55 per share, and a decrease next year of $0.00 per share.
Recursion Pharmaceuticals Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |
Novo Nordisk AS Technical Analysis
May 6 | May 7 | May 8 | May 9 | May 12 | May 13 | May 14 | May 15 | May 16 | May 19 | |
---|---|---|---|---|---|---|---|---|---|---|
May | ||||||||||
06 | 07 | 08 | 09 | 12 | 13 | 14 | 15 | 16 | 19 | |
Technical Analysis: Buy or Sell? | ||||||||||
8-day SMA: | ||||||||||
20-day SMA: | ||||||||||
50-day SMA: | ||||||||||
200-day SMA: | ||||||||||
8-day EMA: | ||||||||||
20-day EMA: | ||||||||||
50-day EMA: | ||||||||||
200-day EMA: | ||||||||||
MACD (12, 26): | ||||||||||
Relative Strength Index (14 RSI): | ||||||||||
Bollinger Bands (25): | ||||||||||
Bollinger Bands (100): |